1 January 2016 in Journal of Clinical and Diagnostic Research
DBDara Balaji Gandhi Babu
+2
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.
10 January 2016 in British Journal of Medicine and Medical Research
NCNallan C. S. K. Chaitanya
Nallan C. S. K. Chaitanya
The oral mucosa represents the first part of the digestive tract and is exposed to various exogenous toxins. Exposure for longer duration can lead to changes that lead to potentially malignant diseases or cancers / Tumors. Eventually these can be diagnosed by routine histopathology, but few of them are difficult to diagnose by this method alone. There arises the role of tumor markers in distinguishing different pathologies is well established. A marker can be described as some inconspicuous object used to distinguish or mark certain things. Mostly tumor markers are proteins and these markers may be detected within exfoliated or distributed cells, or as circulating agents within the peripheral blood or plasma. In the recent years, there is a renewed interest about tumor markers, providing window of opportunity for management of cancer patients by enhancing the efficiency in detection and treatment plan. Recent technological advancement has enabled the examination of many potential markers. This paper focuses on the tumor markers in the head and neck neoplasm.
1 January 2013 in European Journal of Dentistry
The sudden, stabbing, paroxysmal pain of neuralgia is the fiercest agony that a patient may experience in his life. Many varied medical treatments and surgical procedures have been suggested in the literature for neuralgic pain. Most of the patients fail to respond to medical treatments or succumb to complications of total anesthesia owing to surgical procedures. Herein, we tried a new treatment modality in patients suffering from postherpetic neuralgia with appreciable success in all the three cases that are presented in this paper. Streptomycin sulfate dissolved in 2% lidocaine solution was deposited at the peripheral branches on the involved nerves targeting the trigger zones, given weekly once for a maximum of 6 week period and continued once in 2 weeks if symptoms persisted. All patients were followed-up for 1 year and there was a marked improvement on follow-up.
1 January 2013 in International Journal of Contemporary Surgery
GENE therapy represents a fundamentally new way to treat a disease. The use of genetic material (genes), which can express a protein in the cell or interfere with the synthesis of a protein in the cell, in order to treat a disease, is gene therapy. Replacing a defective gene with a normal gene and thus restoring the lost gene function in the patient's body is the essence of gene therapy. Originally conceived as an approach to treat autosomal recessive Mendelian disorders, it is now being applied to a broad range of acquired conditions such as cancers, infections and degenerative disorders. With the understanding of the genetic basis of cancer, an entirely new approach to the treatment of cancer using gene transfer techniques has evolved. DNA is now slated to be used as a therapeutic agent to replace defective genes in patients suffering from genetic disorders or to kill tumor cells in cancer patients.